Trending...
- Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
At Exeter Orthodontics in Exton, patients can choose between traditional braces and Invisalign aligners.
EXTON, Pa. - PennZone -- Both traditional braces and Invisalign aligners are available from Exeter Orthodontics in Exton. While there are differences between the two treatments, both are available for only $3,995. Included in this low price are X-rays, retainers, adjustments, repairs, aligner trays, and emergency visits.
"Our goal is to make high-quality care affordable and accessible to those who need it most," says Dr. John Pardini, orthodontist in Exton.
To keep costs low, Exeter Orthodontics buys materials in bulk. The office only performs braces and Invisalign treatments to limit overhead. This enhanced efficiency means added cost savings for patients.
While braces use wires and brackets affixed to a patient's teeth, Invisalign uses transparent, removable aligners to straighten teeth over time. Traditional braces have a higher compliance because they are attached to the teeth. However, Invisalign has become popular because of its comfort and convenience.
More on The PennZone
During a free consultation, Dr. Pardini and his team will walk through the difference between braces and Invisalign in Exton. They will help patients decide which treatment option is best for their unique needs.
To learn more about braces in Exton from Exeter Orthodontics, request an appointment by visiting https://exeterorthodontics.com/request-appointment/. New patients are welcome.
About Exeter Orthodontics: For several years, Exeter Orthodontics, a Pennsylvania-based orthodontic practice, has offered area patients braces and Invisalign treatments for as low as $3,995. Its team of orthodontists remains dedicated to providing high-quality care at an affordable price. Learn more at http://www.exeterorthodontics.com/.
"Our goal is to make high-quality care affordable and accessible to those who need it most," says Dr. John Pardini, orthodontist in Exton.
To keep costs low, Exeter Orthodontics buys materials in bulk. The office only performs braces and Invisalign treatments to limit overhead. This enhanced efficiency means added cost savings for patients.
While braces use wires and brackets affixed to a patient's teeth, Invisalign uses transparent, removable aligners to straighten teeth over time. Traditional braces have a higher compliance because they are attached to the teeth. However, Invisalign has become popular because of its comfort and convenience.
More on The PennZone
- Corner Property Management AAMC Awarded Community Management Contract for Belvidere at Doyle Square
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- TrueDriveCost Launches Free Calculators for the Real Cost of Owning a Car
- A New Era Of Social Networking Is Here !
- Poetry Quarterly Returns in Print With Its Fall 2026 Issue, Featuring 42 Poets
During a free consultation, Dr. Pardini and his team will walk through the difference between braces and Invisalign in Exton. They will help patients decide which treatment option is best for their unique needs.
To learn more about braces in Exton from Exeter Orthodontics, request an appointment by visiting https://exeterorthodontics.com/request-appointment/. New patients are welcome.
About Exeter Orthodontics: For several years, Exeter Orthodontics, a Pennsylvania-based orthodontic practice, has offered area patients braces and Invisalign treatments for as low as $3,995. Its team of orthodontists remains dedicated to providing high-quality care at an affordable price. Learn more at http://www.exeterorthodontics.com/.
Source: Exeter Orthodontics
Filed Under: Health
0 Comments
Latest on The PennZone
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
- The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
- Pittsburgh Family Law Firm Pollock Begg Celebrates 16th Consecutive Best Law Firms Ranking
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- A Powerful Encounter Awaits Philadelphia: Dr. Mattie Nottage Joins Brother Marcus on Air
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- Beyond Spots & Dots Spreads Holiday Cheer at Old Economy Village's Festival of Trees
- ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
- AI Trading Agents Analyze Pharmaceutical Stocks as Biotech Innovation Draws Attention (LLY, GILD, BSX, AZN, ABBV, MRNA)
- Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
- Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
- PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
- Hope Survives Announces Hidden Impact, Its Second Brain Injury Podcast
- Household Staffing Recognized as Principal Benefactor of the Nanny Relief Fund
- KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
- Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc